销售价格: | ¥ N/A |
商品编号: | AI-0138-1864 |
软件语言: | 英文 |
器械分类: | II |
生产厂家: | Cortechs.ai |
公司网址: | https://www.cortechs.ai/ |
认证信息: | FDA |
系统要求: | Windows |
交付方式: | 下载安装 |
OnQ™ Prostate
Next-Level Prostate Imaging
OnQ Prostate is an FDA-cleared software solution using Restriction Spectrum Imaging (RSI), a patented diffusion MRI method that has been shown to improve detection, in vivo characterization, and localization of clinically significant cancer.
Improved accuracy for quality reads
Through clear, easy-to-interpret images OnQ™ Prostate empowers collaborative decision-making and enhances targeting for biopsy and therapy. Elevating clinical workflows that use MRI for prostate cancer detection, monitoring, and treatment, it helps bridge the gaps between radiologists and referring physicians.
Benefits
OnQ™ Prostate outputs
OnQ™ Prostate achieves improved PI-RADS accuracy and inter-reader agreement.
Restricted signal Map
Shows areas of restricted diffusion with increasedconspicuity compared to acquired and computedhigh b-value DWl
Color Fusion Map
Automatically fuses the restricted signal with the T2for anatomic localization.
Understanding CPT Codes for Prostate MRI Analysis
Prostate MRI plays a critical role in detecting and evaluating prostate cancer, and the availability of Category I CPT codes ensures that providers can seek reimbursement for these essential imaging services.
“This technology has allowed for improved prostate cancer detection, specifically by helpingdistinguish aggressive lesions from normal prostate tissue.”
“RSl augments our ability to identify important cancers and provide precision care with quality exams, effectivelyassisting in Pl-RADS scoring and biopsy targeting"
“lt is my expectation that the utilization of RSl in clinical practice wil result in fewer unnecessary"
“Restriction $pectrum lmaging increases diagnostic confidence particularly in cases with borderline features on standard diffusion-weighted imaging"
“The new RSl-MRl, which maps lesions far more accurately than any prior MRl sequence we have used, unlocks a “next generation" of far more focal radiotherapy methods to ablate localizedprostate cancer"
“RSl is an exciting technology which has the potential to improve substantially both the accuracy and reproducibility of prostate MRl over the current standard reflected in PI-RADS,
“RSl (Restriction $pectrum lmaging) technology saved my life! l had a negative standard MRls andtwo rounds of biopsies while my PSA continued to rise. A few weeks later l had an RSl-MRl foranother reason which detected two prostate tumors that were confirmed by MRl and ultrasoundguided biopsy. l am grateful that my clinically significant prostate cancer was properly diagnosecand treated before it was too late"
非常抱歉,您只有购买软件后才能查看完整软件教程!